Aimmune Therapeutics Overview

Life ScienceCompany

Was Aimmune Therapeutics formerly PE-backed?

Yes. Aimmune Therapeutics was formerly owned by 1 private investor.

Where is Aimmune Therapeutics headquartered?

Aimmune Therapeutics is headquartered in Brisbane, California.

What sector is Aimmune Therapeutics in?

Aimmune Therapeutics is a life science company.

When was Aimmune Therapeutics founded?

Aimmune Therapeutics was founded in 2011.

Aimmune Therapeutics, Inc.

8000 Marina Boulevard, Suite 300,
Brisbane, California 94005
United States,
(650) 614-5220
www.aimmune.com

Aimmune Therapeutics, Inc a clinical-stage biopharmaceutical company, is developing desensitization treatments to help protect people with food allergies by potentially reducing the risk of allergic reactions, making accidental exposures to food allergens less dangerous. Aimmune was formed in 2011 and is based in Brisbane, California.



Try Mergr Free — See This and 220,830+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.